Increased CVD Risk in Young Adults With Elevated Non-HDL-C Revisiting the "Ticking Clock" Hypothesis

被引：0
|
作者：
Miller, Michael [1 ]
机构：
[1] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 74卷 / 01期
关键词：
cardiovascular disease prevention; lipids; non-HDL cholesterol; CARDIOVASCULAR-DISEASE; CHOLESTEROL; ATHEROSCLEROSIS; TRIGLYCERIDES; LIPOPROTEIN; ASSOCIATION; MEN;
D O I：
10.1016/j.jacc.2019.04.048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 82
页数：3
相关论文
共 50 条
  • [41] High level of high-density lipoprotein cholesterol (HDL-C) does not attenuate increased risk of elevated triglycerides
    Williams, C
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (19) : 2385 - 2385
  • [42] Statin Therapy Alters the Relationship Between Apolipoprotein B and Both LDL-C and Non-HDL-C In High-Risk Patients: Effect of Race and Ethnic Background
    Ballantyne, Christie M.
    Nicholls, Stephen J.
    Barter, Philip J.
    Cain, Valerie A.
    Raichlen, Joel S.
    CIRCULATION, 2008, 118 (18) : S1151 - S1151
  • [43] Achievement of non-HDL-C and apo B goals in high-risk patients who achieve their Atp III LDL-C goal: Mercury II trial
    Ballantyne, CM
    Raichlen, JS
    Cain, VA
    Sager, PT
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 101 - 101
  • [44] Switching from statin monotherapy to ezetimibe/simvastatin (e/s) or rosuvastatin (r) modifies ApoB, LDL-C and non-HDL-C correlations with hypocholesterolemic patients in high risk of CHD
    Vaverkova, H.
    Farnier, M.
    Dong, Q.
    Shah, A.
    Johnson-Levonas, A.
    Brudi, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 809 - 809
  • [45] A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductioni-iv
    H V T Ho
    J L Sievenpiper
    A Zurbau
    S Blanco Mejia
    E Jovanovski
    F Au-Yeung
    A L Jenkins
    V Vuksan
    European Journal of Clinical Nutrition, 2016, 70 : 1239 - 1245
  • [46] EZETIMIBE/SIMVASTATIN (E/S) AND ATORVASTATIN (A) TREATMENT MODIFY APOB, LDL-C, AND NON-HDL-C CORRELATIONS IN METABOLIC SYNDROME (MS) PATIENTS AT MODERATELY HIGH RISK(MHR)/HIGH RISK(HR) FOR CHD
    Ballantyne, C.
    Grundy, S.
    Hsueh, W.
    Parving, H.
    Robinson, J.
    Rosen, J.
    Lin, J.
    Lowe, R.
    Shah, A.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [47] Elevated triglyceride-glucose index associated with increased risk of diabetes in non-obese young adults: a longitudinal retrospective cohort study from multiple Asian countries
    Han, Jian
    Dai, Weifeng
    Chen, Lixia
    Huang, Zhenhua
    Li, Chengzhi
    Wang, Keke
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [48] Maintaining High Physical Activity in Young Adulthood is Associated With Lower Cardiovascular Disease (CVD) and Non-CVD Mortality through Middle Age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study
    Murillo, Rosenda
    Badon, Sylvia E.
    Colangelo, Laura A.
    De Chavez, Peter John D.
    Hankinson, Arlene L.
    Liu, Kiang
    Siddique, Juned
    Church, Timothy
    Lewis, Cora E.
    Schreiner, Pamela J.
    Shay, Christina M.
    Sternfeld, Barbara
    Carnethon, Mercedes R.
    CIRCULATION, 2013, 128 (22)
  • [49] Triglyceride to HDL-C Ratio and Increased Arterial Stiffness in Children, Adolescents, and Young Adults (vol 131, pg e1082, 2013)
    Urbina
    PEDIATRICS, 2013, 132 (04) : 780 - 780
  • [50] Age, Abdominal Obesity, and Baseline hsCRP Are Associated with LDL-C, Non-HDL-C and ApoB Responses to Lipid-Lowering Therapy in Patients with Metabolic Syndrome and Moderately High/High CHD Risk
    Robinson, Jennifer G.
    Ballantyne, Christie M.
    Hsueh, Willa A.
    Rosen, Jeffrey B.
    Lin, Jianxin
    Shah, Arvind K.
    Tomassini, Joanne E.
    Lowe, Robert S.
    Tershakovec, Andrew M.
    DIABETES, 2011, 60 : A188 - A188
12345